
NUTEX HEALTH INC
NUTXNASDAQTrading Snapshot
- Day Range
- $165.25 โ $167.28
- 52-Week Range
- $77.21 โ $204.00
- Volume
- $1.74B
- Avg Volume
- $1.24B
- Shares Outstanding
- 6.9M
- Next Earnings
- Oct 10, 2026
Fundamentals Snapshot
- Annual Revenue
- $875M
- Last Q Revenue
- $211M
- P/E Ratio
- 6.3
- P/S Ratio
- 1.4x
- EPS (TTM)
- $26.85
- Dividend Yield
- 0.00%
Why Investors Own NUTX
- โHigh-growth profile โ revenue up +2.3% YoY with expanding US Equity exposure.
- โHealthy economics โ 31% gross margin and 5% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About NUTEX HEALTH INC
Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates
Lake Street Maintains Buy on Nutex Health, Raises Price Target to $310
Lake Street analyst Ben Haynor maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $235 to $310.

Nutex Health Inc. (NUTX) Q2 2026 Earnings Call Transcript
Nutex Health Inc. (NUTX) Q2 2026 Earnings Call August 7, 2026 10:30 AM EDTCompany ParticipantsVivian Sanders - Director of MarketingThomas Vo - Chairman of...
Nutex Health Q2 EPS $9.38 Beats $4.95 Estimate, Sales $210.752M Miss $215.031M Estimate
Nutex Health (NASDAQ:NUTX) reported quarterly earnings of $9.38 per share which beat the analyst consensus estimate of $4.95 by 89.49 percent. This is a 417.97 percent increase over losses of $(2.95) per share from the